The structure of human interferon-β:: implications for activity

被引:94
作者
Karpusas, M [1 ]
Whitty, A [1 ]
Runkel, L [1 ]
Hochman, P [1 ]
机构
[1] Biogen Inc, Cambridge, MA 02142 USA
关键词
interferon; crystal structure; cytokine; aggregation; glycosylation; multiple sclerosis;
D O I
10.1007/s000180050248
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Interferons (IFNs) are potent extracellular protein mediators of host defence and homoeostasis. This article reviews the structure of human IFN-beta (HuIFN-beta), in particular in relation to its activity. The recently determined crystal structure of HuIFN-beta provides a framework for understanding of the mechanism of differentiation of type I IFNs by their common receptor. Insights are generated by comparison with the structures of other type I IFNs and from the interpretation of existing mutagenesis data. The details of the observed carbohydrate structure, together with biochemical data, implicate the glycosylation of HuIFN-beta, which is uncommon among type I IFNs, as an important factor in the solubility; stability and, consequently, activity of the protein. Finally, these structural implications are discussed in the context of the clinical use of HuIFN-beta.
引用
收藏
页码:1203 / 1216
页数:14
相关论文
共 72 条
[21]   REQUIREMENT FOR MAP KINASE (ERK2) ACTIVITY IN INTERFERON-ALPHA-STIMULATED AND INTERFERON-BETA-STIMULATED GENE-EXPRESSION THROUGH STAT PROTEINS [J].
DAVID, M ;
PETRICOIN, E ;
BENJAMIN, C ;
PINE, R ;
WEBER, MJ ;
LARNER, AC .
SCIENCE, 1995, 269 (5231) :1721-1723
[22]   ENGINEERED DISULFIDE BOND GREATLY INCREASES SPECIFIC ACTIVITY OF RECOMBINANT MURINE INTERFERON-BETA [J].
DAY, C ;
SCHWARTZ, B ;
LI, BL ;
PESTKA, S .
JOURNAL OF INTERFERON RESEARCH, 1992, 12 (02) :139-143
[23]   HUMAN GROWTH-HORMONE AND EXTRACELLULAR DOMAIN OF ITS RECEPTOR - CRYSTAL-STRUCTURE OF THE COMPLEX [J].
DEVOS, AM ;
ULTSCH, M ;
KOSSIAKOFF, AA .
SCIENCE, 1992, 255 (5042) :306-312
[24]   CLONING AND EXPRESSION OF A LONG FORM OF THE BETA-SUBUNIT OF THE INTERFERON ALPHA-BETA RECEPTOR THAT IS REQUIRED FOR SIGNALING [J].
DOMANSKI, P ;
WITTE, M ;
KELLUM, M ;
RUBINSTEIN, M ;
HACKETT, R ;
PITHA, P ;
COLAMONICI, OR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (37) :21606-21611
[25]   GAMMA-INTERFERON IS THE LYMPHOKINE AND BETA-INTERFERON THE MONOKINE RESPONSIBLE FOR INHIBITION OF FIBROBLAST COLLAGEN PRODUCTION AND LATE BUT NOT EARLY FIBROBLAST PROLIFERATION [J].
DUNCAN, MR ;
BERMAN, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 1985, 162 (02) :516-527
[26]  
DUQUETTE P, 1995, NEUROLOGY, V45, P1277
[27]  
Duquette P, 1996, NEUROLOGY, V47, P889
[28]  
FLORES I, 1991, J BIOL CHEM, V266, P19875
[29]   CYTOKINE THERAPEUTICS - LESSONS FROM INTERFERON-ALPHA [J].
GUTTERMAN, JU .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (04) :1198-1205
[30]   DIMERIZATION OF CELL-SURFACE RECEPTORS IN SIGNAL-TRANSDUCTION [J].
HELDIN, CH .
CELL, 1995, 80 (02) :213-223